3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
135
Precursor Cell Lymphoblastic Leukemia-Lymphoma
85
Hematologic Neoplasms
76
Leukemia, Lymphocytic, Chronic, B-Cell
74
Leukemia
55
Myelodysplastic Syndromes
52
Lymphoma
38
Lymphoma, Non-Hodgkin
33
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
33
Multiple Myeloma
24
Burkitt Lymphoma
23
Leukemia, Myelomonocytic, Chronic
21
Recurrence
20
Neoplasms
18
Lymphoma, Large B-Cell, Diffuse
17
Hodgkin Disease
17
Leukemia, B-Cell
16
Myeloproliferative Disorders
15
Lymphoma, Mantle-Cell
15
Lymphoma, B-Cell
15
Lymphoma, Follicular
13
Leukemia, Biphenotypic, Acute
12
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma, B-Cell, Marginal Zone
11
Waldenstrom Macroglobulinemia
10
Anemia, Refractory, with Excess of Blasts
10
Blast Crisis
9
Primary Myelofibrosis
7
Leukemia, Hairy Cell
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Muscular Atrophy
×
Other hematologic neoplasm
×
30 days
×
Clear all
NCT05296096
2026-05-29
PROXIMUS
Boston Children's Hospital
Phase NA
Completed
18 enrolled